# EDGAR Filing Document

**Accession Number:** 0001501989
**File Stem:** 0001193125-26-227057
**Filing Date:** 2026-5
**Character Count:** 24079
**Document Hash:** 0a892b4101be97899ff398a7ff810789
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-227057.hdr.sgml**: 20260515

**ACCESSION NUMBER**: 0001193125-26-227057

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13G/A

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260515

**DATE AS OF CHANGE**: 20260515

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CytomX Therapeutics, Inc.
- **CENTRAL INDEX KEY:** 0001501989
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 273521219
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13G/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-89140
- **FILM NUMBER:** 26989100

**BUSINESS ADDRESS:**
- **STREET 1:** 151 OYSTER POINT BLVD.
- **STREET 2:** SUITE 400
- **CITY:** SOUTH SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94080
- **BUSINESS PHONE:** 650.515.3185

**MAIL ADDRESS:**
- **STREET 1:** 151 OYSTER POINT BLVD.
- **STREET 2:** SUITE 400
- **CITY:** SOUTH SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94080
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Longitude Capital Partners V, LLC
- **CENTRAL INDEX KEY:** 0002018312

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13G/A

**BUSINESS ADDRESS:**
- **STREET 1:** 2740 SAND HILL ROAD
- **STREET 2:** 2ND FLOOR
- **CITY:** MENLO PARK
- **STATE:** CA
- **ZIP:** 94025
- **BUSINESS PHONE:** 650-854-5700

**MAIL ADDRESS:**
- **STREET 1:** 2740 SAND HILL ROAD
- **STREET 2:** 2ND FLOOR
- **CITY:** MENLO PARK
- **STATE:** CA
- **ZIP:** 94025

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13G

### Under the Securities Exchange Act of 1934

**(Amendment No. 1)**

**Issuer:** CytomX Therapeutics, Inc.

**Title of Class of Securities:** Common Stock, $0.00001 par value per share

**CUSIP Number:** —

**Date of Event Which Requires Filing of this Statement:** 03/31/2026

**Check the appropriate box to designate the rule pursuant to which this Schedule is filed:**

- [ ] Rule 13d-1(b)

- [x] Rule 13d-1(c)

- [ ] Rule 13d-1(d)

---

| 1. | Names of Reporting Persons<br>Longitude Capital Partners V, LLC | Names of Reporting Persons<br>Longitude Capital Partners V, LLC |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [x] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [x] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>DE | Citizenship or Place of Organization<br>DE |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>0 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>12458461 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>0 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>12458461 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>12458461 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>12458461 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>5.7% | Percent of Class Represented by Amount in Row (9)<br>5.7% |
| 12. | Type of Reporting Person (See Instructions)<br>OO | Type of Reporting Person (See Instructions)<br>OO |

**Comment for Type of Reporting Person:** All such shares are held of record by LVPV (as defined in Item 2(a) below). LCPV (as defined in Item 2(a) below) is the general partner of LVPV and may be deemed to have voting, investment and dispositive power with respect to these securities. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LCPV and may each be deemed to share voting, investment and dispositive power with respect to these securities.

Based on 217,702,919 shares of Common Stock (as defined in Item 2(d) below) outstanding as of April 30, 2026, as reported by the Issuer (as defined in Item 1(a) below) in its quarterly report on Form 10-Q filed with the Securities and Exchange Commission (the Commission) on May 7, 2026 (the Form 10-Q).

---

| 1. | Names of Reporting Persons<br>Longitude Venture Partners V, L.P. | Names of Reporting Persons<br>Longitude Venture Partners V, L.P. |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [x] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [x] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>DE | Citizenship or Place of Organization<br>DE |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>0 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>12458461 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>0 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>12458461 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>12458461 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>12458461 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>5.7% | Percent of Class Represented by Amount in Row (9)<br>5.7% |
| 12. | Type of Reporting Person (See Instructions)<br>PN | Type of Reporting Person (See Instructions)<br>PN |

**Comment for Type of Reporting Person:** All such shares are held of record by LVPV. LCPV is the general partner of LVPV and may be deemed to have voting, investment and dispositive power with respect to these securities. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LCPV and may each be deemed to share voting, investment and dispositive power with respect to these securities.

Based on 217,702,919 shares of Common Stock outstanding as of April 30, 2026, as reported by the Issuer in the Form 10-Q.

---

| 1. | Names of Reporting Persons<br>Longitude 103.8 East Partners, LLC | Names of Reporting Persons<br>Longitude 103.8 East Partners, LLC |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [x] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [x] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>DE | Citizenship or Place of Organization<br>DE |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>0 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>2830000 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>0 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>2830000 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>2830000 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>2830000 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>1.3% | Percent of Class Represented by Amount in Row (9)<br>1.3% |
| 12. | Type of Reporting Person (See Instructions)<br>OO | Type of Reporting Person (See Instructions)<br>OO |

**Comment for Type of Reporting Person:** All shares are held of record by L103 (as defined in Item 2(a) below). L103P (as defined in Item 2(a) below) is the general partner of L103 and may be deemed to have voting, investment and dispositive power with respect to these securities. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of L103P and may each be deemed to share voting, investment and dispositive power with respect to these securities.

Based on 217,702,919 shares of Common Stock outstanding as of April 30, 2026, as reported by the Issuer in the Form 10-Q.

---

| 1. | Names of Reporting Persons<br>Longitude 103.8 East, L.P. | Names of Reporting Persons<br>Longitude 103.8 East, L.P. |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [x] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [x] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>DE | Citizenship or Place of Organization<br>DE |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>0 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>2830000 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>0 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>2830000 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>2830000 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>2830000 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>1.3% | Percent of Class Represented by Amount in Row (9)<br>1.3% |
| 12. | Type of Reporting Person (See Instructions)<br>PN | Type of Reporting Person (See Instructions)<br>PN |

**Comment for Type of Reporting Person:** All shares are held of record by L103. L103P is the general partner of L103 and may be deemed to have voting, investment and dispositive power with respect to these securities. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of L103P and may each be deemed to share voting, investment and dispositive power with respect to these securities.

Based on 217,702,919 shares of Common Stock outstanding as of April 30, 2026, as reported by the Issuer in the Form 10-Q.

---

| 1. | Names of Reporting Persons<br>Patrick G. Enright | Names of Reporting Persons<br>Patrick G. Enright |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [x] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [x] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>X1 | Citizenship or Place of Organization<br>X1 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>0 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>15288461 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>0 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>15288461 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>15288461 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>15288461 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>7.0% | Percent of Class Represented by Amount in Row (9)<br>7.0% |
| 12. | Type of Reporting Person (See Instructions)<br>IN | Type of Reporting Person (See Instructions)<br>IN |

**Comment for Type of Reporting Person:** Consists of (i) 12,458,461 shares of Common Stock held of record by LVPV, and (ii) 2,830,000 shares of Common Stock held of record by L103. LCPV is the general partner of LVPV and may be deemed to have voting, investment and dispositive power with respect to the shares held of record by LVPV. L103P is the general partner of L103 and may be deemed to have voting, investment and dispositive power with respect to the shares held by L103. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of each of LCPV and L103P and may each be deemed to share voting, investment and dispositive power with respect to the shares held by LVPV and L103.

Based on 217,702,919 shares of Common Stock outstanding as of April 30, 2026, as reported by the Issuer in the Form 10-Q.

---

| 1. | Names of Reporting Persons<br>Juliet Tammenoms Bakker | Names of Reporting Persons<br>Juliet Tammenoms Bakker |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [x] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [x] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>X1 | Citizenship or Place of Organization<br>X1 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>0 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>15288461 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>0 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>15288461 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>15288461 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>15288461 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>7.0% | Percent of Class Represented by Amount in Row (9)<br>7.0% |
| 12. | Type of Reporting Person (See Instructions)<br>IN | Type of Reporting Person (See Instructions)<br>IN |

**Comment for Type of Reporting Person:** Consists of (i) 12,458,461 shares of Common Stock held of record by LVPV, and (ii) 2,830,000 shares of Common Stock held of record by L103. LCPV is the general partner of LVPV and may be deemed to have voting, investment and dispositive power with respect to the shares held of record by LVPV. L103P is the general partner of L103 and may be deemed to have voting, investment and dispositive power with respect to the shares held by L103. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of each of LCPV and L103P and may each be deemed to share voting, investment and dispositive power with respect to the shares held by LVPV and L103.

Based on 217,702,919 shares of Common Stock outstanding as of April 30, 2026, as reported by the Issuer in the Form 10-Q.

---

**Item 1(a). Name of Issuer:**
CytomX Therapeutics, Inc.

**Item 1(b). Address of Issuer's Principal Executive Offices:**
151 Oyster Point Blvd, Suite 400, South San Francisco, CA 94080

**Item 2(a). Name of Person Filing:**
This joint statement on Schedule 13G is being filed by Longitude Capital Partners V, LLC (LCPV), Longitude Venture Partners V, L.P. (LVPV), Longitude 103.8 East Partners, LLC (L103P) and Longitude 103.8 East, L.P. (L103, and together with LCPV, LVPV and L103P the Reporting Entities) and Patrick G. Enright and Juliet Tammenoms Bakker (together, the Reporting Individuals). The Reporting Entities and the Reporting Individuals are collectively referred to as the Reporting Persons.

**Item 2(b). Address of Principal Business Office:**
The address of the principal business office of each Reporting Person is 2740 Sand Hill Road, 2nd Floor, Menlo Park, CA 94025.

**Item 2(c). Citizenship:**
LCPV and L103P are each a limited liability company organized under the laws of the State of Delaware. LVPV and L103 are each a limited partnership organized under the laws of the State of Delaware. Each of the Reporting Individuals is a citizen of the United States of America.

**Item 2(d). Title of Class of Securities:**
Common Stock, $0.00001 par value per share

**Item 2(e). CUSIP Number:**
—

**Item 3. If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:**

(a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

(b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

(c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

(d) [ ] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

(e) [ ] An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

(f) [ ] An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

(g) [ ] A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

(h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i) [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j) [ ] A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), if filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:

(k) [ ] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).

**Item 4. Ownership:**

**(a) Amount beneficially owned:**

See Row 9 of the cover page for each Reporting Person. LVPV is the record owner of 12,458,461 shares of Common Stock (the LVPV Shares). As general partner of LVPV, LCPV may be deemed to beneficially own the LVPV Shares. L103 is the record owner of 2,830,000 shares of Common Stock (the L103 Shares). As general partner of L103, L103P may be deemed to beneficially own the L103 Shares. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LCPV and L103P and may be deemed to share voting, investment and dispositive power with respect to the LVPV Shares and the L103 Shares.
Except to the extent of his, hers, or its pecuniary interest therein, each Reporting Person disclaims beneficial ownership of such shares of Common Stock, except for the shares, if any, such Reporting Person holds of record.
Longitude Capital Management Co., LLC (LCM), the investment advisor of LVPV and L103, and Seven Fleet Advisors LLC (together with its affiliates, Seven Fleet) have instituted policies and procedures that may affect the acquisition, holding and disposition of securities held by Seven Fleet. As a result of such policies and procedures, the Reporting Persons and Seven Fleet may be deemed to be members of a group within the meaning of Section 13(d)(3) of the Exchange Act.
As of the date hereof, based on information provided by or on behalf of Seven Fleet, Seven Fleet may be deemed to be the beneficial owner of 1,085,398 shares of Common Stock, constituting 0.5% of the number of shares of Common Stock based on 217,702,919 shares of Common Stock outstanding as of April 30, 2026, as reported by the Issuer in the Form 10-Q. Notwithstanding such policies and procedures, the Reporting Persons expressly disclaim such group membership and beneficial ownership over any Common Stock that they may be deemed to beneficially own by reason of such policies and procedures. This Schedule 13G shall not be deemed an admission that the Reporting Persons are members of a group for purposes of Section 13 of the Exchange Act or for any other purpose.

**(b) Percent of class:**

See Row 11 of the cover page for each Reporting Person and the corresponding footnotes.*

**(c) Number of shares as to which the person has:**

**(i) Sole power to vote or to direct the vote:**

See Row 5 of the cover page for each Reporting Person and the corresponding footnotes.*

**(ii) Shared power to vote or to direct the vote:**

See Row 6 of the cover page for each Reporting Person and the corresponding footnotes.*

**(iii) Sole power to dispose or to direct the disposition of:**

See Row 7 of the cover page for each Reporting Person and the corresponding footnotes.*

**(iv) Shared power to dispose or to direct the disposition of:**

See Row 8 of the cover page for each Reporting Person and the corresponding footnotes.*

**Item 5. Ownership of Five Percent or Less of a Class.**

[x] If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following.

**Item 6. Ownership of More than 5 Percent on Behalf of Another Person.**

Under certain circumstances set forth in the limited partnership agreements of LVPV and L103 and the limited liability company agreements of LCPV and L103P, the general and limited partners or members, as the case may be, of each of such entities may be deemed to have the right to receive dividends from, or the proceeds from, the sale of securities of the Issuer owned by each such entity of which they are a partner or member, as the case may be.

**Item 7. Identification and Classification of the Subsidiary**

Not Applicable

**Item 8. Identification and Classification of Members of the Group**

Not Applicable

**Item 9. Notice of Dissolution of Group**

Not Applicable

**Item 10. Certification:**

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Longitude Capital Partners V, LLC**

**Date:** 05/15/2026

**By:** /s/ Cristiana Blauth Oliveira

**Name & Title:** Cristiana Blauth Oliveira, Authorized Signatory

**Longitude Venture Partners V, L.P.**

**Date:** 05/15/2026

**By:** /s/ Cristiana Blauth Oliveira

**Name & Title:** Cristiana Blauth Oliveira, Authorized Signatory

**Longitude 103.8 East Partners, LLC**

**Date:** 05/15/2026

**By:** /s/ Cristiana Blauth Oliveira

**Name & Title:** Cristiana Blauth Oliveira, Authorized Signatory

**Longitude 103.8 East, L.P.**

**Date:** 05/15/2026

**By:** By Longitude 103.8 East Partners, LLC, General Partner, /s/ Cristiana Blauth Oliveira

**Name & Title:** Cristiana Blauth Oliveira, Authorized Signatory

**Patrick G. Enright**

**Date:** 05/15/2026

**By:** /s/ Cristiana Blauth Oliveira

**Name & Title:** Cristiana Blauth Oliveira, as attorney-in-fact for Patrick G. Enright

**Juliet Tammenoms Bakker**

**Date:** 05/15/2026

**By:** /s/ Cristiana Blauth Oliveira

**Name & Title:** Cristiana Blauth Oliveira, as attorney-in-fact for Juliet Tammenoms Bakker